by | Dec 24, 2022 | News
The coronavirus has been a shifty foe, with new variants and subvariants rapidly evolving to evade vaccines and treatments. Researchers at Boston’s Dana-Farber Cancer Institute are working on an experimental drug that takes one of the virus’ most dangerous traits —... by | Dec 23, 2022 | News
Teens and young adults who are treated for sleep disorders with benzodiazepines such as Xanax – a medication commonly prescribed to treat anxiety and insomnia – may be at a higher risk of overdose, according to Rutgers researchers. The study, published in JAMA Network... 
by | Dec 23, 2022 | News
Maria Laura ‘Marila’ Gennaro, whose research focuses on diagnosing tuberculosis (TB) and the antibody response to the SARS-CoV-2 infection that causes COVID-19, has been recognized as an academic inventor making a tangible impact on quality of life, economic... by | Dec 22, 2022 | News
Teenagers and young adults who use benzodiazepines to treat insomnia may be at heightened risk of overdose, a new study finds. Benzodiazepines include anxiety medications like Ativan, Klonopin, Valium and Xanax, as well as prescription sleep aids such as estazolam... by | Dec 22, 2022 | News
This program is part academic fellowship and part startup accelerator. The START Entrepreneurs will conduct academic research with faculty on campus and receive entrepreneurship education and mentorship while building fundable, early-stage new ventures such as startup...